CDH1 and inflammatory breast carcinoma: In summary, our study provides strong evidence that DCN suppresses aggressive growth, tumorigenesis, and metastasis in IBC via a newly discovered mechanism that involves the degradation of E-cadherin protein and inhibition of the E-cadherin–EGFR axis.